Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Bijl

Showing results (61-70 of 91) with videos related to

Pageof 10
Sort By:
Arthritis and Rheumatism|June 7, 2013
Efficacy and safety of ocrelizumab in active proliferative lupus nephritis: results from a randomized, double-blind, phase III studyEduardo F Mysler, Alberto J Spindler, Renato Guzman, et al.
Nederlands Tijdschrift Voor Geneeskunde|November 17, 2011
[The multidisciplinary practice guideline "The responsible use of biologicals"]J W J Hans Bijlsma, J W Annemarie Hagemeijer, Marc Bijl, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 1, 2014
Folate receptor-β imaging using 99mTc-folate to explore distribution of polarized macrophage populations in human atherosclerotic plaqueNynke A Jager, Johanna Westra, Reza Golestani, et al.
Clinical Immunology (Orlando, Fla.)|September 6, 2011
Cell-mediated immune responses to inactivated trivalent influenza-vaccination are decreased in patients with common variable immunodeficiencySander van Assen, Aalzen de Haan, Albert Holvast, et al.
The Journal of Rheumatology|August 3, 2020
Effects of Childhood-onset Systemic Lupus Erythematosus on Academic Achievements and Employment in Adult LifeNoortje Groot, Anne Kardolus, Marc Bijl, et al.
Annals of the Rheumatic Diseases|July 15, 2009
Cell-mediated immune responses to influenza vaccination in Wegener's granulomatosisAlbert Holvast, Aalzen de Haan, Sander van Assen, et al.
RMD Open|February 25, 2021
Point of view on the vaccination against COVID-19 in patients with autoimmune inflammatory rheumatic diseasesVictoria Furer, Christien Rondaan, Nancy Agmon-Levin, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 3, 2012
Targeted folate receptor β fluorescence imaging as a measure of inflammation to estimate vulnerability within human atherosclerotic carotid plaqueNynke A Jager, Johanna Westra, Gooitzen M van Dam, et al.
Arthritis and Rheumatism|March 1, 2007
Treatment with cyclophosphamide delays the progression of chronic lesions more effectively than does treatment with azathioprine plus methylprednisolone in patients with proliferative lupus nephritisCecile Grootscholten, Ingeborg M Bajema, Sandrine Florquin, et al.
Arthritis and Rheumatism|December 30, 2009
Humoral responses after influenza vaccination are severely reduced in patients with rheumatoid arthritis treated with rituximabSander van Assen, Albert Holvast, Cornelis A Benne, et al.
Pageof 10

Showing results (61-70 of 91) with videos related to

Sort By:
Pageof 10
Arthritis and Rheumatism|June 7, 2013
Efficacy and safety of ocrelizumab in active proliferative lupus nephritis: results from a randomized, double-blind, phase III studyEduardo F Mysler, Alberto J Spindler, Renato Guzman, et al.
Nederlands Tijdschrift Voor Geneeskunde|November 17, 2011
[The multidisciplinary practice guideline "The responsible use of biologicals"]J W J Hans Bijlsma, J W Annemarie Hagemeijer, Marc Bijl, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 1, 2014
Folate receptor-β imaging using 99mTc-folate to explore distribution of polarized macrophage populations in human atherosclerotic plaqueNynke A Jager, Johanna Westra, Reza Golestani, et al.
Clinical Immunology (Orlando, Fla.)|September 6, 2011
Cell-mediated immune responses to inactivated trivalent influenza-vaccination are decreased in patients with common variable immunodeficiencySander van Assen, Aalzen de Haan, Albert Holvast, et al.
The Journal of Rheumatology|August 3, 2020
Effects of Childhood-onset Systemic Lupus Erythematosus on Academic Achievements and Employment in Adult LifeNoortje Groot, Anne Kardolus, Marc Bijl, et al.
Annals of the Rheumatic Diseases|July 15, 2009
Cell-mediated immune responses to influenza vaccination in Wegener's granulomatosisAlbert Holvast, Aalzen de Haan, Sander van Assen, et al.
RMD Open|February 25, 2021
Point of view on the vaccination against COVID-19 in patients with autoimmune inflammatory rheumatic diseasesVictoria Furer, Christien Rondaan, Nancy Agmon-Levin, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 3, 2012
Targeted folate receptor β fluorescence imaging as a measure of inflammation to estimate vulnerability within human atherosclerotic carotid plaqueNynke A Jager, Johanna Westra, Gooitzen M van Dam, et al.
Arthritis and Rheumatism|March 1, 2007
Treatment with cyclophosphamide delays the progression of chronic lesions more effectively than does treatment with azathioprine plus methylprednisolone in patients with proliferative lupus nephritisCecile Grootscholten, Ingeborg M Bajema, Sandrine Florquin, et al.
Arthritis and Rheumatism|December 30, 2009
Humoral responses after influenza vaccination are severely reduced in patients with rheumatoid arthritis treated with rituximabSander van Assen, Albert Holvast, Cornelis A Benne, et al.
Pageof 10